Holick MF - Search Results

1

Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin.

Flanagan JN, Whitlatch LW, Chen TC, Zhu XH, Holick MT, Kong XF, Holick MF. Flanagan JN, et al. Among authors: holick mt, holick mf. J Invest Dermatol. 2001 Jun;116(6):910-4. doi: 10.1046/j.1523-1747.2001.01360.x. J Invest Dermatol. 2001. PMID: 11407980 Free article.

2

The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes.

Chen TC, Persons K, Liu WW, Chen ML, Holick MF. Chen TC, et al. Among authors: holick mf. J Invest Dermatol. 1995 Jan;104(1):113-7. doi: 10.1111/1523-1747.ep12613601. J Invest Dermatol. 1995. PMID: 7798628 Free article.

3

Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes.

Chen ML, Heinrich G, Ohyama YI, Okuda K, Omdahl JL, Chen TC, Holick MF. Chen ML, et al. Among authors: holick mf. Proc Soc Exp Biol Med. 1994 Oct;207(1):57-61. doi: 10.3181/00379727-207-43791. Proc Soc Exp Biol Med. 1994. PMID: 7938037

4

Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3.

Chen ML, Perez A, Sanan DK, Heinrich G, Chen TC, Holick MF. Chen ML, et al. Among authors: holick mf. J Invest Dermatol. 1996 Apr;106(4):637-41. doi: 10.1111/1523-1747.ep12345443. J Invest Dermatol. 1996. PMID: 8617997 Free article. Clinical Trial.

5

Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective.

Holick MF, Chen ML, Kong XF, Sanan DK. Holick MF, et al. J Investig Dermatol Symp Proc. 1996 Apr;1(1):1-9. J Investig Dermatol Symp Proc. 1996. PMID: 9627684 Review.

6

Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene.

Kong XF, Zhu XH, Pei YL, Jackson DM, Holick MF. Kong XF, et al. Among authors: holick mf. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6988-93. doi: 10.1073/pnas.96.12.6988. Proc Natl Acad Sci U S A. 1999. PMID: 10359826 Free PMC article.

7

Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.

Chen TC, Holick MF. Chen TC, et al. Among authors: holick mf. Br J Dermatol. 2000 Jul;143(1):72-8. doi: 10.1046/j.1365-2133.2000.03593.x. Br J Dermatol. 2000. PMID: 10886138

8

1,25-dihydroxyvitamin D3: a novel agent for enhancing wound healing.

Tian XQ, Chen TC, Holick MF. Tian XQ, et al. Among authors: holick mf. J Cell Biochem. 1995 Sep;59(1):53-6. doi: 10.1002/jcb.240590107. J Cell Biochem. 1995. PMID: 8530536

9

Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Schwartz GG, et al. Among authors: holick mf. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):391-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610788

10

The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.

Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF. Chen TC, et al. Among authors: holick mf. Clin Cancer Res. 2000 Mar;6(3):901-8. Clin Cancer Res. 2000. PMID: 10741714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters